RecruitingNot ApplicableNCT05890417

Evolution of Sexual Life Quality of Women With POI Before and After Introduction of Hormone Replacement Therapy

Sponsor

University Hospital, Bordeaux

Enrollment

135 participants

Start Date

Jul 17, 2023

Study Type

INTERVENTIONAL

Conditions

Premature Ovarian Failure

Summary

The aim of this study is to evaluate the evolution of quality of sex life of women with POI after introduction hormone replacement therapy through the FSFI scale

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying questionnaire for people with premature ovarian failure. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 40 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERquestionnaire

Female Sexual Function Index (FSFI) and WHO Quality of Life-BREF (WHOQOL-BREF) questionnaires at baseline and 6 months after starting hormone replacement therapy

Locations(1)

CHU Bordeaux

Bordeaux, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05890417

Related Trials

Autologous PRP Infusion May Restore Ovarian Function and May Promote Folliculogenesis in POI Patients

NCT040314561 location

Is There A Role For Mechanical Stimulation In Ovarian Follicular Activation?

NCT043903081 location

The Danish TURNER Cryopreservation Study

NCT057405791 location